1. Home
  2. GRWG vs VTVT Comparison

GRWG vs VTVT Comparison

Compare GRWG & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

N/A

Current Price

$1.27

Market Cap

89.6M

ML Signal

N/A

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

N/A

Current Price

$21.00

Market Cap

104.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRWG
VTVT
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.6M
104.9M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
GRWG
VTVT
Price
$1.27
$21.00
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$2.50
★ $56.00
AVG Volume (30 Days)
★ 283.3K
14.2K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.22
N/A
EPS
N/A
★ N/A
Revenue
★ $193,365,479.00
N/A
Revenue This Year
$2.33
N/A
Revenue Next Year
$3.82
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 142.51
N/A
52 Week Low
$1.01
$20.56
52 Week High
$2.40
$44.00

Technical Indicators

Market Signals
Indicator
GRWG
VTVT
Relative Strength Index (RSI) 31.19 22.64
Support Level $1.04 N/A
Resistance Level $1.58 $34.65
Average True Range (ATR) 0.08 1.40
MACD -0.01 -0.34
Stochastic Oscillator 30.43 4.59

Price Performance

Historical Comparison
GRWG
VTVT

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: